Register
Login:
Share:
Email Facebook Twitter

FUM Share Chat - RSS Feed

Futura Medical Share Chat (FUM)



Share Price: 51.00Bid: 50.50Ask: 51.50Change: 0.25 (+0.49%)Riser - Futura Med.
Spread: 1.00Spread as %: 1.98%Open: 50.75High: 51.00Low: 50.75Yesterday’s Close: 50.75



Share Discussion for Futura Med. (FUM)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


lurker
Posts: 903
Off Topic
Opinion:No Opinion
Price:105.00
£2
4 Apr '12
£2 - Yes please - sold to the man in the suit - Thank and bank
 
lurker
Posts: 903
Off Topic
Opinion:No Opinion
Price:105.00
Boom
4 Apr '12
BOOM - not often you can say that in FUM
Farley_Granger
Posts: 623
Off Topic
Opinion:No Opinion
Price:105.00
Now paying full ask
4 Apr '12
£1.06 with high volumes.
FAB
Farley_Granger
Posts: 623
Observation
Opinion:No Opinion
Price:105.00
Take over speculation ........
4 Apr '12
could go up to £2.00 per share
From The Mail Online :
Shares of the AIM-listed healthcare firm, which is sitting on two potentially explosive products in the sexual enhancement field, rose 2.5p to 101p on hot gossip that Reckitt Benckiser and Australia’s Ansell are both willing to pay up to £2 a share to gain full control of the Surrey-based company.
They would love to get their hands on Futura’s most exciting new prospect
Farley_Granger
Posts: 623
Off Topic
Opinion:No Opinion
Price:97.50
Annual report ....
2 Apr '12
...... now available for download.
FAG
SatellitePro
Posts: 481
Research
Opinion:Strong Buy
Price:95.00
JS
1 Apr '12
Take-over talks mentioned in the Daily Telegraph should help stabilise the SP and could push it significantly higher.
jimmysmits
Posts: 322
Off Topic
Opinion:Strong Buy
Price:90.50
FUM
15 Mar '12
Got a decent mention in the Motley Fool today
pddy
Posts: 52
Observation
Opinion:No Opinion
Price:96.50
July launch for PET500
13 Mar '12
"PET500 will be marketed as part of Ansell's LifeStyles® brand and it is expected that it will be launched from July in a phased roll-out throughout the USA. We expect recurring royalty income to begin to flow this year but as the launch is phased the initial royalties are likely to be relatively modest."

http://www.futuramedical.co.uk/content/financial/financial_results.asp

Wonder if we'll have a launch date for CSD500 by then!?
SatellitePro
Posts: 481
Research
Opinion:Strong Buy
Price:99.00
£££££ From..
13 Mar '12
I joined Futura after more than 35 years at GlaxoSmithKline, most recently as the President of its Consumer Healthcare division. My executive career has given me considerable experience of the consumer healthcare sector, which I believe is reliant on one thing: innovation.
Futura is a company with innovation at its core. It also has a great team of people, which it is a privilege for me to join. Its DermaSys® delivery system is at the forefront of transdermal drug delivery, a delivery route that is particularly appealing for OTC products. DermaSys® creates the opportunity for Futura to develop organically into a substantial business.
It is my intention to help Futura realise the full potential of its market opportunities whilst also using my experience of global companies to assist in its licensing strategy.
2012 promises to be a very exciting year for Futura with two products close to launch and a pipeline of further opportunities at various stages of development. I look forward to contributing to the Company's success.

John Clarke
Chairman
SatellitePro
Posts: 481
Research
Opinion:No Opinion
Price:99.00
Prelims
13 Mar '12



Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs

Sign up for Live Prices
Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.